Completed NA INTERVENTIONAL NCT00437853

Neoadjuvant Hormonal Treatment of Postmenopausal Women Who Have Operable Breast Cancer

Sponsor: AstraZeneca

Interventions Anastrozole

Updated 5 times since 2017 Last updated: Feb 20, 2007 Started: Jun 30, 2003 Completion: Feb 28, 2007

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Breast Cancer and is currently completed. AstraZeneca leads this study, which shows 5 recorded versions since 2003 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

5 versions recorded

Sep 2025 — Present [monthly]

Completed NA
Sep 2024 — Sep 2025 [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jan 2017 — Jan 2021 [monthly]

Completed NA

First recorded

Jun 2003

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

AstraZeneca
Instituto Nacional de Cancerologia de Mexico

Data source: Instituto Nacional de Cancerologia de Mexico

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Mexico City, Mexico